ATE529402T1 - 3',6-substituierte indirubine und ihre biologischen anwendungen - Google Patents

3',6-substituierte indirubine und ihre biologischen anwendungen

Info

Publication number
ATE529402T1
ATE529402T1 AT08161646T AT08161646T ATE529402T1 AT E529402 T1 ATE529402 T1 AT E529402T1 AT 08161646 T AT08161646 T AT 08161646T AT 08161646 T AT08161646 T AT 08161646T AT E529402 T1 ATE529402 T1 AT E529402T1
Authority
AT
Austria
Prior art keywords
biological applications
substituted
halogen
alkyl
indirubins
Prior art date
Application number
AT08161646T
Other languages
English (en)
Inventor
Laurent Meijer
Leandros Skaltsounis
Emmanuel Mikros
Prokopios Magiatis
Carl Johnson
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE529402T1 publication Critical patent/ATE529402T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08161646T 2008-08-01 2008-08-01 3',6-substituierte indirubine und ihre biologischen anwendungen ATE529402T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08161646A EP2149553B1 (de) 2008-08-01 2008-08-01 3',6-substituierte Indirubine und ihre biologischen Anwendungen

Publications (1)

Publication Number Publication Date
ATE529402T1 true ATE529402T1 (de) 2011-11-15

Family

ID=40225521

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08161646T ATE529402T1 (de) 2008-08-01 2008-08-01 3',6-substituierte indirubine und ihre biologischen anwendungen
AT09802595T ATE547401T1 (de) 2008-08-01 2009-07-21 3',6-substituierte indirubine und ihre biologische anwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT09802595T ATE547401T1 (de) 2008-08-01 2009-07-21 3',6-substituierte indirubine und ihre biologische anwendung

Country Status (6)

Country Link
US (1) US8829203B2 (de)
EP (2) EP2149553B1 (de)
JP (1) JP5577336B2 (de)
AT (2) ATE529402T1 (de)
CA (1) CA2732232C (de)
WO (1) WO2010013168A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552053B2 (en) * 2005-12-23 2013-10-08 Centre National De La Recherche Scientifique 7-substituted indirubin-3′oximes and their applications
EP2149553B1 (de) 2008-08-01 2011-10-19 Centre National de la Recherche Scientifique 3',6-substituierte Indirubine und ihre biologischen Anwendungen
JP6091893B2 (ja) 2009-07-08 2017-03-08 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 機能的に分化した体細胞の増強された自己再生を誘導するための方法
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
US9051306B2 (en) * 2011-07-15 2015-06-09 Nihon University Indirubin derivative having highly selective cytotoxicity for malignant tumors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9512076B2 (en) 2012-02-03 2016-12-06 City Of Hope Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia
US10435367B2 (en) * 2013-03-14 2019-10-08 City Of Hope Indirubin derivatives, and uses thereof
WO2013142817A2 (en) 2012-03-23 2013-09-26 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
AU2014236370C1 (en) 2013-03-14 2019-01-17 City Of Hope 5-bromo-indirubins
US20150259288A1 (en) 2014-03-14 2015-09-17 City Of Hope 5-bromo-indirubins
KR102247795B1 (ko) * 2017-10-31 2021-05-04 주식회사 펠레메드 급성 골수성 백혈병 또는 전이성 유방암의 예방 또는 치료용 약제학적 조성물
EP4010337A4 (de) 2019-11-04 2023-08-23 CK Regeon Inc. Zusammensetzungen und verfahren zur unterdrückung und/oder behandlung von neurodegenerativen erkrankungen und/oder eines klinischen zustands davon
CN113072540B (zh) * 2021-03-29 2023-07-14 贵州医科大学 一种靛玉红衍生的降解剂及其制备与应用
WO2022229986A1 (en) * 2021-04-29 2022-11-03 Jawaharlal Nehru Centre For Advanced Scientific Research Indirubin compounds and methods thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541244A (ja) 1999-04-12 2002-12-03 ゲルハルト アイゼンブランド インジゴイドビスインドール誘導体
AU2004285522A1 (en) * 2003-10-28 2005-05-12 Centre National De La Recherche Scientifique Indirubin-type compounds, compositions, and methods for their use
US8552053B2 (en) 2005-12-23 2013-10-08 Centre National De La Recherche Scientifique 7-substituted indirubin-3′oximes and their applications
EP2149553B1 (de) 2008-08-01 2011-10-19 Centre National de la Recherche Scientifique 3',6-substituierte Indirubine und ihre biologischen Anwendungen

Also Published As

Publication number Publication date
WO2010013168A1 (en) 2010-02-04
JP2011529873A (ja) 2011-12-15
US8829203B2 (en) 2014-09-09
EP2149553A1 (de) 2010-02-03
JP5577336B2 (ja) 2014-08-20
EP2149553B1 (de) 2011-10-19
EP2328866B1 (de) 2012-02-29
ATE547401T1 (de) 2012-03-15
CA2732232A1 (en) 2010-02-04
EP2328866A1 (de) 2011-06-08
US20110136808A1 (en) 2011-06-09
CA2732232C (en) 2017-11-07

Similar Documents

Publication Publication Date Title
ATE529402T1 (de) 3',6-substituierte indirubine und ihre biologischen anwendungen
BRPI0606524A2 (pt) derivados de indol para o tratamento de infecções virais
MX2010001170A (es) Derivados de imidazolona, metodo de preparacion de los mismos y uso biologico de los mismos.
CY1109727T1 (el) Παραγωγα ν3 αλκυλιωμενου βενζιμιδαζολιου ως αναστολεις μεκ
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
MY149934A (en) 4-substituted phenoxyphenylacetic acid derivatives
CY1112914T1 (el) Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης
CO6241115A2 (es) Compuestos y composiciones como inhibidores de protein quinasas
NZ596538A (en) Haloalkyl heteroaryl benzamide compounds
EP2013196A4 (de) Disubstituierte anilinverbindungen
CY1112691T1 (el) Αναστολεις αντιγραφης ιου ανθρωπινης ανοσοανεπαρκειας
BRPI1009235A8 (pt) acetamidas substítuidas por 2-(hetero)arila, n-(hetero)arila e seus usos, e composição farmacêutica
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA201170176A1 (ru) Ингибитор stat3, содержащий хинолинкарбоксамидное производное в качестве активного ингредиента
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA200700286A1 (ru) Применение замещённых производных 2-пирролидона в качестве фунгицидов и инсектицидов
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
JOP20200326A1 (ar) مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها
EA201000069A1 (ru) Новые гербициды
EA200970497A1 (ru) Производные пиррола, их получение и их применение в терапии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties